No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236
about
Stereotactic body radiotherapy in lung cancer: an updateComplications from Stereotactic Body Radiotherapy for Lung CancerChallenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.Stereotactic radiotherapy for early stage non-small cell lung cancerLungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveRegional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235SBRT Treatment of Metachronous Small-Cell and Non-Small-Cell Lung Carcinomas in a Patient with Severe COPD.Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumorsManagement and postoperative outcome in primary lung cancer and heart disease co-morbidity: a systematic review and meta-analysis.Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance)A lot to a little or a little to a lot-which dose-volume relationship ensures the best clinical outcome in the high dose radiation therapy of thoracic tumors? A prospective approach.Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients.Pulmonary Function Changes After Radiotherapy for Lung or Esophageal Cancer: A Systematic Review Focusing on Dose-Volume Parameters.The changing paradigm of tumour response to irradiation.Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.Changes in pulmonary function and influencing factors after high-dose intrathoracic radio(chemo)therapy.Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.Sparing healthy lung by focusing the radiation beam flow onto the emphysematous regions in the treatment of lung cancer.Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer-Experiences from a Single Institution.Optimizing the prescription isodose level in stereotactic volumetric-modulated arc radiotherapy of lung lesions as a potential for dose de-escalation.The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions
P2860
Q26781806-4ED3021D-CAA9-42E2-947A-3F4BE11459DFQ26995851-91F76714-7C96-41A2-9E6B-E26607848ECCQ28083924-1A490D22-3097-4DB9-A6D4-4E29DA68B05CQ30992150-487EB2A6-DC16-48EF-9FC4-3115364C67A1Q35824255-4BDB36E1-6A41-4999-8D65-1AA1FA1C23C7Q36235727-EA9644A5-9D8A-4EBE-AA1B-A6E3D6F14B74Q36288418-18080B98-CF45-4C37-93AC-2D02B698B8F4Q36493928-2633E03B-2484-442E-86C6-D93B27C169B8Q36686913-F7B746B3-6938-4AB2-8CBD-CD9A89B85F37Q37027257-1D65FDD0-29C8-4710-B00A-6149DFB5CD48Q37193638-2BEF7A93-5CBA-464C-AB8E-7CC567E16DA0Q37208686-5E683C55-801C-4CEA-9337-604550020BD7Q37384166-4B9CF451-6F72-4F41-B25C-D849571939E4Q37491637-4BBBDCF9-AA07-4B90-B08E-7F380CC8C886Q38560967-D70BF418-4D7D-46AE-BD72-4A0F8B302048Q38678310-9A6715CF-0B04-40EF-83BC-24426BB23B28Q38896870-DFA363A9-21AB-41F2-A2C4-C7E9E70B689FQ39052564-6CEA3700-70B1-461C-B5BE-AAFC32BCF8EEQ39248242-3FCD1EE7-2532-4F4D-86A3-B7CC07661DBBQ39342656-0E9C8544-3326-46B3-BD00-12A4561A450AQ39369286-119ED8FA-6FCA-4074-8E0E-D55B85BDED2CQ42154657-3063A517-32D6-4802-BC5A-A4678F39D6B8Q49749018-098E5779-5724-4EE6-BDE0-70840EFF1FA1Q50138849-75B64EB4-6ED5-4E5A-9FCA-786429A4FBDBQ51621075-071636F7-7105-407D-B4E5-A5E54CDBB9ECQ57177641-9494B243-BBE7-44B8-889E-CFBD31182445
P2860
No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@ast
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@en
type
label
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@ast
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@en
prefLabel
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@ast
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@en
P2093
P2860
P1476
No clinically significant chan ...... ncer: an analysis of RTOG 0236
@en
P2093
Andrea Bezjak
Gregory M M Videtic
Jeff M Michalski
Jeffrey Bradley
Rebecca Paulus
Robert B Barriger
Robert D Timmerman
Sinisa Stanic
P2860
P304
P356
10.1016/J.IJROBP.2013.12.050
P407
P577
2014-04-01T00:00:00Z